Academisch Ziekenhuis Maastricht
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1986-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mumc.nl
Clinical Trials
131
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Timely Recovery After Subclinical Heart Failure
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Academisch Ziekenhuis Maastricht
- Target Recruit Count
- 130
- Registration Number
- NCT06341101
- Locations
- 🇳🇱
AZMaastricht, Maastricht, Limburg, Netherlands
Detecting Otoconia With CT-Scan
- Conditions
- BPPV
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Academisch Ziekenhuis Maastricht
- Registration Number
- NCT05969340
Perioperative Energy Expenditure in Major Liver Resection
- Conditions
- Liver NeoplasmsCancerLiver Diseases
- First Posted Date
- 2023-07-05
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Academisch Ziekenhuis Maastricht
- Target Recruit Count
- 20
- Registration Number
- NCT05931068
- Locations
- 🇳🇱
Maastricht University Medical Center+, Maastricht, Netherlands
Patient Recorded Indexing Measurements
- Conditions
- CancerWeight, BodyCachexia
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Academisch Ziekenhuis Maastricht
- Target Recruit Count
- 300
- Registration Number
- NCT05899205
- Locations
- 🇳🇱
Maastricht University Medical Center+, Maastricht, Netherlands
🇳🇱Zuyderland Medical Center, Sittard, Netherlands
Chronic Pain Rehabilitation in Patients With Small Fiber Neuropathy
- Conditions
- Small Fiber Neuropathy
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Academisch Ziekenhuis Maastricht
- Target Recruit Count
- 10
- Registration Number
- NCT05798949
- Locations
- 🇳🇱
Adelante Zorggroep, Maastricht, Limburg, Netherlands
🇳🇱Maastricht University Medical Center, Maastricht, Netherlands
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
Maastricht UMC+ Develops Promising Drug for Hereditary Fructose Intolerance Treatment
Researchers at Maastricht UMC+ have successfully tested a novel drug that blocks toxin accumulation in patients with hereditary fructose intolerance, potentially eliminating the need for strict dietary restrictions.